Table 1 Estimated PCV7 and PCV13 coverages (%) in 2012–2013.
Age Group | %PCV7 (schedule) | %PCV13 (schedule) |
|---|---|---|
<12 mo | - | 70 (3+1) |
12–59 mo | - | 95 (2+1) |
≥60 mo-<15 y | 50 (3+1) | - |
Age Group | %PCV7 (schedule) | %PCV13 (schedule) |
|---|---|---|
<12 mo | - | 70 (3+1) |
12–59 mo | - | 95 (2+1) |
≥60 mo-<15 y | 50 (3+1) | - |